Page last updated: 2024-08-18

pyrroles and Cancer of Gallbladder

pyrroles has been researched along with Cancer of Gallbladder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lorenz, J; Mössner, J; Wiedmann, M; Wolf, S1
Ahmadzadeh, A; Babaei, M; Elahi, F; Hassanpour, K; Yadollahzadeh, M1
DiGiovanni, J; Franco, E; Fujiwara, K; Hanai, M; Kawamoto, T; Kiguchi, K; Kurakata, S; Ruffino, L; Rumi, M1

Other Studies

3 other study(ies) available for pyrroles and Cancer of Gallbladder

ArticleYear
Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
    World journal of gastroenterology, 2010, Jan-14, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Biliary Tract Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Proto-Oncogene Proteins c-akt; Pteridines; Pyrimidines; Pyrroles; Receptor, IGF Type 1

2010
Neuroendocrine tumor of the gallbladder.
    Archives of Iranian medicine, 2013, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Neuroendocrine; Catheter Ablation; Cisplatin; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Female; Gallbladder; Gallbladder Neoplasms; Gemcitabine; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib; Taxoids; Ultrasonography

2013
Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:6

    Topics: Administration, Oral; Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; ErbB Receptors; Fluorescent Antibody Technique; Gallbladder Neoplasms; Mice; Mice, Transgenic; Pyrroles; Receptor, ErbB-2; Sulfonamides

2007